Hepatitis C virus infection after liver transplantation is associated with lower levels of activated CD4+CD25+CD45RO +IL-7Rαhigh T cells

Liver Transplantation

Volumn 16, Issue 1, 2010, Pages 49-55

  Ciuffreda, Donatella ^a,b   Codarri, Laura ^a   Buhler, Leo ^b,c   Vallotton, Laure ^a   Giostra, Emiliano ^b,c   Mentha, Gilles ^b,c   Morel, Philippe ^b,c   Pantaleo, Giuseppe ^a   Pascual, Manuel ^a,b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD45RO ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 7 RECEPTOR ALPHA;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GRAFT RECIPIENT; HEPATITIS C; HUMAN; LIVER GRAFT; LIVER TRANSPLANTATION; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; VIREMIA;

ADULT; AGED; ANTIVIRAL AGENTS; CASE-CONTROL STUDIES; DOWN-REGULATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 73949133531     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21959     Document Type: Article

References (18)

1. Berenguer M, Lopez-Labrador FX, Wright TL. Hepatitis C and liver transplantation. J Hepatol 2001;35:666-678.
2. Wright T, Donegan E, Hsu H, Ferrel L, Lake JR, Kim M, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992;103:317-322.
3. Berenguer M, Prieto M, Rayon JM, Mora J, Pastor M, Ortiz V, et al. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatology 2000;32:852-858.
4. Berenguer M, Ferrell L, Watson J, Prieto M, Kim M, Rayon M, et al. HCV-related cirrhosis progression following liver transplantation: increase in recent years. J Hepatol 2000; 32:673-684.
5. Charlton M, Seaberg E. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Liver Transpl Surg 1999;5:S107-S114.
6. Rosen HR, Hinrichs DJ, Leistikow RL, Callender G, Wertheimer AM, Nishimura MI, et al. Cutting edge: identification of HCV-specific CD8 T cells restricted by donor HLA alleles following liver transplantation. J Immunol 2004; 173:5355-5359.
7. Casavilla FA, Rakela J, Kapur S, Irish W, McMichael J, Demetris AJ, et al. Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus. Liver Transpl Surg 1998;4:448-454.
8. Golden-Mason L, Burton JR, Castelblanco N, Klarquist J, Benloch S, Wang C, et al. Loss of IL-7 receptor alpha chain (CD127) expression in acute HCV infection associated with viral persistence. Hepatology 2006;44:1098-1109.
9. Bengsch B, Spangenberg HC, Kersting N, Neumann-Haefelin C, Panther E, von Weizsäcker F, et al. Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver. J Virol 2007;81:945-953.
10. Prlic M, Lefrançois L, Jameson SC. Multiple choices: regulation of memory CD8T cell generation and homeostasis by interleukin (IL)-7 and IL-15. J Exp Med 2002;195:F49-F52.
11. Kaech SM, Wherry EJ, Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2002;2:251-262.
12. Van Leeuwen EM, de Bree GJ, Remmerswaal EB, Yonq SL, Tesselaar K, ten Berqe IJ, et al. IL-7 receptor alpha chain expression distinguishes functional subsets of virus-specific human CD8+ T cells. Blood 2005;106:2091-2098.
13. Seddiki N, Santaner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A, et al. Expression on interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006;203:1693-1700.
14. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, et al. CD127 expression inversely correlates with Foxp3 and suppressive function of human CD4+T reg cells. J Exp Med 2006;203:1701-1711.
15. high cell population in solid organ transplant recipients. J Exp Med 2007; 204:1533-1541.
16. Fontana M, Ciuffreda D, Moradpour D, Pascual M. Combined antiviral therapy for recurrent hepatitis C virus after liver transplantation. Transplantation 2007;83:525-526.
17. Cabrera R, Tu Z, Xu Y, Firpi RB, Rosen HR, Liu C, et al. An immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in hepatitis C virus infection. Hepatology 2004;40:1062-1071.
18. Sugimoto K, Ikeda F, Stadanlick J, Nunes FA, Alter HJ, Chang KM. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 2003;38:1437-1448.